Connection

Peisheng Xu to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Peisheng Xu has written about Xenograft Model Antitumor Assays.
Peisheng Xu
Connection Strength
0.764
Xenograft Model Antitumor Assays
  1. Redox-Sensitive Nanocomplex for Targeted Delivery of Melittin. Toxins (Basel). 2020 09 10; 12(9).
    View in: PubMed
    Score: 0.163
  2. Carrier-Free Nanoassembly of Curcumin-Erlotinib Conjugate for Cancer Targeted Therapy. Adv Healthc Mater. 2020 10; 9(19):e2001128.
    View in: PubMed
    Score: 0.163
  3. A bioactivatable self-quenched nanogel for targeted photodynamic therapy. Biomater Sci. 2019 Dec 01; 7(12):5143-5149.
    View in: PubMed
    Score: 0.153
  4. Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles. Acta Biomater. 2019 01 15; 84:378-390.
    View in: PubMed
    Score: 0.144
  5. Triple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery. Biomaterials. 2014 Nov; 35(35):9546-53.
    View in: PubMed
    Score: 0.107
  6. Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer. Mol Cancer Res. 2018 09; 16(9):1348-1360.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.